Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)
KRAS-LCS6 多态性在接受厄洛替尼或多西他赛二线治疗的晚期非小细胞肺癌患者中的作用（TAILOR）
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/srep16331
Ganzinelli, Monica; Rulli, Eliana; Caiola, Elisa; Garassino, Marina Chiara; Broggini, Massimo; Copreni, Elena; Piva, Sheila; Longo, Flavia; Labianca, Roberto; Bareggi, Claudia; Fabbri, Maria Agnese; Martelli, Olga; Fagnani, Daniele; Locatelli, Maria Cristina; Bertolini, Alessandro; Valmadre, Giuseppe; Pavese, Ida; Calcagno, Anna; Sarobba, Maria Giuseppa; Marabese, Mirko
